CTOs on the Move

Ossur

www.ossur.com

 
Ossur is in the business of improving people`s mobility. As a leading global company in non-invasive orthopaedics, we deliver advanced and innovative technologies within the fields of prosthetics, braces, supports and compression therapy. Determined to restore maximum biological function to those in need, Össur has more than thirty years` experience in the design and production of high-tech orthopaedic devices. Our work, however, is as much about people as it is about products. Their comfort, confidence and rehabilitation are central to our endeavors. We never forget that every time we develop a product or service, we are helping someone else to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.ossur.com
  • 27051 Towne Centre Dr
    Foothill Ranch, CA USA 92610
  • Phone: 949.362.3883

Executives

Name Title Contact Details

Similar Companies

Halkey-Roberts Corporation

Halkey-Roberts Corporation is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Galil Medical

Galil Medical is a global leader in generating innovative cryotherapy solutions. Our technologies are delivered through multiple physician specialties; we are focused on conditions affecting bone, kidney, liver, lung and prostate as well as targeted pain applications.

Q Macs

Q Macs is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ValenTx

ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.  

SPR Therapeutics

SPR Therapeutics, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.